Literature DB >> 15853669

Pathophysiology of blood-spinal cord barrier in traumatic injury and repair.

Hari Shanker Sharma1.   

Abstract

Blood-spinal cord barrier (BSCB) plays an important role in the regulation of the fluid microenvironment of the spinal cord. Trauma to the spinal cord impairs the BSCB permeability to proteins leading to vasogenic edema formation. Several endogenous neurochemical mediators and growth factors contribute to trauma induced BSCB disruption. Studies carried out in our laboratory suggest that those drugs and neurotrophic factors capable to attenuate the BSCB dysfunction following trauma are neuroprotective in nature. Whereas, agents that do not exert any influence on the BSCB disruption failed to reduce cell injury. These observations are in line with the idea that BSCB disruption plays an important role in the pathophysiology of spinal cord injuries. The probable mechanism(s) of trauma induced BSCB dysfunction and its contribution to cell injuries are discussed.

Entities:  

Mesh:

Year:  2005        PMID: 15853669     DOI: 10.2174/1381612053507837

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  40 in total

1.  In vivo longitudinal MRI and behavioral studies in experimental spinal cord injury.

Authors:  Laura M Sundberg; Juan J Herrera; Ponnada A Narayana
Journal:  J Neurotrauma       Date:  2010-10-09       Impact factor: 5.269

2.  Blood-CNS barrier, neurodegeneration and neuroprotection: recent therapeutic advancements and nano-drug delivery.

Authors:  Hari S Sharma
Journal:  J Neural Transm (Vienna)       Date:  2011-01       Impact factor: 3.575

3.  Sleep restriction impairs blood-brain barrier function.

Authors:  Junyun He; Hung Hsuchou; Yi He; Abba J Kastin; Yuping Wang; Weihong Pan
Journal:  J Neurosci       Date:  2014-10-29       Impact factor: 6.167

4.  Upregulation of miR-199a-5p Protects Spinal Cord Against Ischemia/Reperfusion-Induced Injury via Downregulation of ECE1 in Rat.

Authors:  Ning Bao; Bo Fang; Huangwei Lv; Yanhua Jiang; Fengshou Chen; Zhilin Wang; Hong Ma
Journal:  Cell Mol Neurobiol       Date:  2018-06-13       Impact factor: 5.046

Review 5.  Nanoparticle transport across the blood brain barrier.

Authors:  Andreas M Grabrucker; Barbara Ruozi; Daniela Belletti; Francesca Pederzoli; Flavio Forni; Maria Angela Vandelli; Giovanni Tosi
Journal:  Tissue Barriers       Date:  2016-02-25

6.  Not just the brain: methamphetamine disrupts blood-spinal cord barrier and induces acute glial activation and structural damage of spinal cord cells.

Authors:  Eugene A Kiyatkin; Hari S Sharma
Journal:  CNS Neurol Disord Drug Targets       Date:  2015       Impact factor: 4.388

7.  Nanowired Delivery of Growth Hormone Attenuates Pathophysiology of Spinal Cord Injury and Enhances Insulin-Like Growth Factor-1 Concentration in the Plasma and the Spinal Cord.

Authors:  Dafin F Muresanu; Aruna Sharma; José V Lafuente; Ranjana Patnaik; Z Ryan Tian; Fred Nyberg; Hari S Sharma
Journal:  Mol Neurobiol       Date:  2015-07-01       Impact factor: 5.590

8.  Nanoparticles Exacerbate Both Ubiquitin and Heat Shock Protein Expressions in Spinal Cord Injury: Neuroprotective Effects of the Proteasome Inhibitor Carfilzomib and the Antioxidant Compound H-290/51.

Authors:  Hari S Sharma; Dafin F Muresanu; Jose V Lafuente; Per-Ove Sjöquist; Ranjana Patnaik; Aruna Sharma
Journal:  Mol Neurobiol       Date:  2015-07-01       Impact factor: 5.590

9.  Neutralizing endogenous VEGF following traumatic spinal cord injury modulates microvascular plasticity but not tissue sparing or functional recovery.

Authors:  Richard L Benton; Melissa A Maddie; Mark J Gruenthal; Theo Hagg; Scott R Whittemore
Journal:  Curr Neurovasc Res       Date:  2009-05       Impact factor: 1.990

10.  Transcriptional activation of endothelial cells by TGFβ coincides with acute microvascular plasticity following focal spinal cord ischaemia/reperfusion injury.

Authors:  Richard L Benton; Melissa A Maddie; Toros A Dincman; Theo Hagg; Scott R Whittemore
Journal:  ASN Neuro       Date:  2009-08-26       Impact factor: 4.146

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.